Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Potassium methylxanthate, also known as potassium O-methyl dithiocarbonate, is a chemical compound that exhibits strong inhibitory effects on carbonic anhydrases and demonstrates antiglaucoma effects in vivo. It is a promising candidate for various applications in different industries.

2667-20-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2667-20-1 Structure
  • Basic information

    1. Product Name: Potassium methylxanthate
    2. Synonyms: Potassium methylxanthate;NSC 4849;Dithiocarbonic acid O-methyl S-potassium salt;Dithiocarbonic acid O-methyl=S-potassium salt;Dithiocarbonic acid S-potassium O-methyl ester salt;Methoxydithioformic acid potassium salt;potassium O-methyl carbonodithioate
    3. CAS NO:2667-20-1
    4. Molecular Formula: C2H3KOS2
    5. Molecular Weight: 146.27292
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 2667-20-1.mol
  • Chemical Properties

    1. Melting Point: 237 °C
    2. Boiling Point: 94.1°Cat760mmHg
    3. Flash Point: 10.7°C
    4. Appearance: /
    5. Density: g/cm3
    6. Vapor Pressure: 54.7mmHg at 25°C
    7. Refractive Index: 1.563
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: Potassium methylxanthate(CAS DataBase Reference)
    11. NIST Chemistry Reference: Potassium methylxanthate(2667-20-1)
    12. EPA Substance Registry System: Potassium methylxanthate(2667-20-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 2667-20-1(Hazardous Substances Data)

2667-20-1 Usage

Uses

Used in Pharmaceutical Industry:
Potassium methylxanthate is used as a pharmaceutical agent for its antiglaucoma effects. It helps in reducing intraocular pressure in the eyes, making it a potential treatment for glaucoma patients.
Used in Enzyme Inhibition:
Potassium methylxanthate is used as an enzyme inhibitor for its strong inhibitory effects on carbonic anhydrases. This property can be utilized in various applications where the inhibition of these enzymes is required, such as in the development of drugs for treating certain diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 2667-20-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,6 and 7 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2667-20:
(6*2)+(5*6)+(4*6)+(3*7)+(2*2)+(1*0)=91
91 % 10 = 1
So 2667-20-1 is a valid CAS Registry Number.
InChI:InChI=1/C2H4OS2/c1-3-2(4)5/h1H3,(H,4,5)

2667-20-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Potassium methyl xanthogenate

1.2 Other means of identification

Product number -
Other names potassium O-methyl carbonodithioate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2667-20-1 SDS

2667-20-1Relevant articles and documents

Eosin y catalyzed difunctionalization of styrenes using O2 and CS2: A direct access to 1,3-oxathiolane-2-thiones

Yadav, Arvind K.,Yadav, Lal Dhar S.

, p. 4240 - 4244 (2016)

Visible light promoted straightforward highly regioselective synthesis of 1,3-oxathiolane-2-thiones (cyclic dithiocarbonates) starting directly from styrenes, CS2 and air (O2) is reported. The protocol utilizes eosin Y as an organophotoredox catalyst and clean resources like visible light and air (O2) as sustainable reagents at room temperature in a one-pot procedure. Additionally, the approach is advantageous in terms of step economy as it skips the prefunctionalization of styrenes to oxiranes, which has been inevitable in commonly used syntheses of 1,3-oxathiolane-2-thiones.

Synthesis, characterization, semi-empirical study, and biological activities of organotin(IV) and transition metal complexes with o -methyl carbonodithioate

Javed, Fatima,Ali, Saqib,Shah, Muhammad Wajid,Munawar, Khuram Shahzad,Shahzadi, Saira,Hameedullah,Fatima, Humaira,Ahmed, Madiha,Sharma, Saroj K.,Qanungo, Kushal

, p. 2795 - 2808 (2014)

Three transition metal and six organotin(IV) complexes have been synthesized by treating potassium o-methyl carbonodithioate with ZnCl2/CdCl2/HgCl2 and R2SnCl2/R3SnCl under stirring. The co

Synthesis and crystal structure of bis(O-methyl hydrogenato carbonodithioate)-Pb(II): structural, optical and photocatalytic studies of PbS nanoparticles from the complex

Ajibade, Peter A.,Oluwalana, Abimbola E.

, p. 3575 - 3588 (2019)

Lead(II) methyl xanthate [Pb(S2COMe)2] was synthesized and characterized by single crystal X-ray crystallography. The molecular structure showed a distorted tetrahedral geometry around Pb(II) with each monomeric unit linked with another through Pb???S interactions. The compound was used to prepare hexadecylamine capped PbS (HDA-PbS) and oleylamine capped PbS (OLA-PbS) nanoparticles. The PbS nanoparticles were indexed to the cubic PbS crystalline phase with particle sizes of 4.5–34.5 nm. The estimated optical bandgaps obtained from the tauc’s plots were 3.47 and 3.30 eV for HDA-PbS and OLA-PbS, respectively, which are blue shifted in comparison to bulk PbS. The photodegradation of methylene blue using PbS as photocatalyst shows that HDA-PbS have the best degradation efficiency of 77.70% after 240 min.

The Alkali Metal Salts of Methyl Xanthic Acid

Liebing, Phil,Schmeide, Marten,Kühling, Marcel,Witzorke, Juliane

, p. 2428 - 2434 (2020/06/17)

Methyl xanthates of the type M(SSC-OMe) (M = Li–Cs) are readily formed when carbon disulfide is reacted with the corresponding alkali metal hydroxides in methanol exposed to air, or with the alkali metal methoxides in dry methanol or THF under exclusion of air. The reactions are easily monitored by 13C NMR spectroscopy. The Na, K, Rb, and Cs salt could be isolated in high yields, while the Li salt decomposed upon attempted isolation. All compounds are readily complexed by crown ethers and form isolable 1:1 adducts, including the elusive Li salt. All products were studied by NMR (1H, 13C, and alkali metal nuclei) and IR spectroscopy, and most of them where structurally characterized by single-crystal X-ray diffraction. Li(SSC-OMe)(12c4) (12c4 = [12]crown-4) and Cs(SSC-OMe)(18c6) (18c6 = [18]crown-6) represent the first structurally characterized lithium and caesium xanthate complexes, respectively.

COMPOUNDS, THEIR PREPARATION, RELATED COMPOSITIONS, CATALYSTS, ELECTROCHEMICAL CELLS, FUEL CELLS, AND USES THEREOF

-

Paragraph 0407, (2019/04/25)

In some embodiments, this application relates to inventive compounds (e.g., Formula (I), Formula (II), thiosemicarbazones and/or thiosemicarbazones and their metal (e.g., zinc, cobalt, nickel, or copper) complexes, and extended structures thereof), methods for preparation of the inventive compounds, compositions comprising the inventive compounds (e.g., anode, cathodes, catalysts (e.g., electrocatalysts), glassy carbon electrodes, carbon paste electrodes, covalently modified carbon (e.g., modified graphene)), electrochemical cells comprising compositions that comprise one or more inventive compounds, fuel cells comprising compositions that comprise one or more inventive compounds, uses of one or more inventive compounds to produce H2 (e.g., via an electrochemical cell), and uses of one or more inventive compounds to create energy from H2 (e.g., via a fuel cell). Additional embodiments of the invention are also discussed herein.

Highly efficient structurally characterised novel precatalysts: Di- and mononuclear heteroleptic Cu(i) dixanthate/xanthate-phosphine complexes for azide-alkyne cycloadditions

Anamika,Agrahari, Anand K.,Manar, Krishna K.,Yadav, Chote Lal,Tiwari, Vinod K.,Drew, Michael G. B.,Singh, Nanhai

, p. 8939 - 8949 (2019/06/17)

Novel heteroleptic dinuclear [Cu2(L)(PPh3)4] (L = 2,6-pyridinedimethyldixanthate L1 1, 1,4-benznedimethyldixanthate L2 2, 1,4-cyclohexanedixanthate L3 3) and mononuclear [Cu(L4)(PPh3)2] 4 (L4 = pipero

Important Phase Control of Indium Sulfide Nanomaterials by Choice of Indium(III) Xanthate Precursor and Thermolysis Temperature

Masikane, Siphamandla C.,McNaughter, Paul D.,Lewis, David J.,Vitorica-Yrezabal, Inigo,Doyle, Bryan P.,Carleschi, Emanuela,O'Brien, Paul,Revaprasadu, Neerish

, p. 1421 - 1432 (2019/03/07)

Four In(III) xanthate complexes, [In(S2COR)3] where R = Me, Et, iPr and sBu, respectively, were synthesized, characterized and subsequently used as single source molecular precursors via a solventless thermolysis route to obtain indium sulfide materials. By choice of precursor and reaction temperature crystalline powders of tetragonal In2S3, cubic In2S3 and cubic In2.77S4 were acquired. The phase identification and purity were conducted through examination of the experimental powder X-ray diffraction patterns relative to the simulated patterns for single X-ray crystal diffraction.

Discovery of Potent Protease-Activated Receptor 4 Antagonists with in Vivo Antithrombotic Efficacy

Miller, Michael M.,Banville, Jacques,Friends, Todd J.,Gagnon, Mark,Hangeland, Jon J.,Lavallée, Jean-Fran?ois,Martel, Alain,O'Grady, Harold,Rémillard, Roger,Ruediger, Edward,Tremblay, Fran?ois,Posy, Shana L.,Allegretto, Nick J.,Guarino, Victor R.,Harden, David G.,Harper, Timothy W.,Hartl, Karen,Josephs, Jonathan,Malmstrom, Sarah,Watson, Carol,Yang, Yanou,Zhang, Ge,Wong, Pancras,Yang, Jing,Bouvier, Michel,Seiffert, Dietmar A.,Wexler, Ruth R.,Lawrence, R. Michael,Priestley, E. Scott,Marinier, Anne

, p. 7400 - 7416 (2019/08/26)

In an effort to identify novel antithrombotics, we have investigated protease-activated receptor 4 (PAR4) antagonism by developing and evaluating a tool compound, UDM-001651, in a monkey thrombosis model. Beginning with a high-throughput screening hit, we identified an imidazothiadiazole-based PAR4 antagonist chemotype. Detailed structure-activity relationship studies enabled optimization to a potent, selective, and orally bioavailable PAR4 antagonist, UDM-001651. UDM-001651 was evaluated in a monkey thrombosis model and shown to have robust antithrombotic efficacy and no prolongation of kidney bleeding time. This combination of excellent efficacy and safety margin strongly validates PAR4 antagonism as a promising antithrombotic mechanism.

Accessing γ-Ga2S3 by solventless thermolysis of gallium xanthates: A low-temperature limit for crystalline products

Alderhami, Suliman A.,Collison, David,Lewis, David J.,McNaughter, Paul D.,O'Brien, Paul,Spencer, Ben F.,Vitorica-Yrezabal, Inigo,Whitehead, George

, p. 15605 - 15612 (2019/11/03)

Alkyl-xanthato gallium(iii) complexes of the form [Ga(S2COR)3], where R = Me (1), Et (2), iPr (3), nPr (4), nBu (5), sBu (6) and iBu (7), have been synthesized and fully characterised. The crystal structures for 1 and 3-7 have been solved and examined to elucidate if these structures are related to their decomposition. Thermogravimetric analysis was used to gain insight into the decomposition temperatures for each complex. Unlike previously explored metal xanthate complexes which break down at low temperatures (2S3 was the sole product formed. In the case of R = Me, Chugaev elimination did not occur and amorphous GaxSy products were formed. We conclude therefore that the low-temperature synthesis route offered by the thermal decomposition of metal xanthate precursors, which has been reported for many metal sulfide systems prior to this, may not be appropriate in the case of gallium sulfides.

Synthesis of nanostructured powders and thin films of iron sulfide from molecular precursors

Almanqur, Laila,Vitorica-Yrezabal, Inigo,Whitehead, George,Lewis, David J.,O'Brien, Paul

, p. 29096 - 29103 (2018/08/29)

Iron(iii) xanthate single-source precursors [Fe(S2COR)3] (R = methyl, ethyl, isopropyl and 1-propyl) were used to deposit iron sulfide thin films and nanostructures by two simple, efficient and low-cost methods (spin coating and solid state deposition). The single-crystal X-ray structures of the iron(iii) n-propyl xanthate and iron(iii) iso-propyl xanthate have been determined. Thermogravimetric analysis (TGA) studies of the complexes shows that decomposition of the complexes produces iron sulfide, pyrite or trolite. The crystallinity of iron sulfide thin films and powder samples was studied using X-ray diffraction (XRD), and their morphology was studied by scanning electron microscopy (SEM).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2667-20-1